8.85 USD
+0.13 (+1.49%)
8.85 USD
0 (0%)
JYNT gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 101 industry peers in the Health Care Providers & Services industry. The financial health of JYNT is average, but there are quite some concerns on its profitability. JYNT is valued correctly, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year JYNT has reported negative net income.
In the past year JYNT had a positive cash flow from operations.
In multiple years JYNT reported negative net income over the last 5 years.
Each year in the past 5 years JYNT had a positive operating cash flow.
1.2 Ratios
JYNT has a Return On Assets of -1.40%. This is comparable to the rest of the industry: JYNT outperforms 44.55% of its industry peers.
The Return On Equity of JYNT (-4.27%) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.4% | ||
| ROE | -4.27% | ||
| ROIC | N/A |
ROA(3y)-7.05%
ROA(5y)1.52%
ROE(3y)-28.39%
ROE(5y)0.48%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
JYNT has a Gross Margin of 78.26%. This is amongst the best in the industry. JYNT outperforms 93.07% of its industry peers.
JYNT's Gross Margin has declined in the last couple of years.
JYNT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 78.26% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.87%
GM growth 5Y-2.53%
2. Health
2.1 Basic Checks
JYNT does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for JYNT has been increased compared to 1 year ago.
JYNT has more shares outstanding than it did 5 years ago.
There is no outstanding debt for JYNT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
JYNT has an Altman-Z score of 2.80. This is not the best score and indicates that JYNT is in the grey zone with still only limited risk for bankruptcy at the moment.
JYNT's Altman-Z score of 2.80 is fine compared to the rest of the industry. JYNT outperforms 61.39% of its industry peers.
There is no outstanding debt for JYNT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 2.8 |
ROIC/WACCN/A
WACC9.07%
2.3 Liquidity
A Current Ratio of 1.83 indicates that JYNT should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.83, JYNT is in the better half of the industry, outperforming 73.27% of the companies in the same industry.
JYNT has a Quick Ratio of 1.83. This is a normal value and indicates that JYNT is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of JYNT (1.83) is better than 76.24% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.83 | ||
| Quick Ratio | 1.83 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 99.03% over the past year.
JYNT shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -24.15%.
Measured over the past years, JYNT shows a small growth in Revenue. The Revenue has been growing by 1.36% on average per year.
EPS 1Y (TTM)99.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%109.52%
Revenue 1Y (TTM)-24.15%
Revenue growth 3Y-13.43%
Revenue growth 5Y1.36%
Sales Q2Q%-55.69%
3.2 Future
Based on estimates for the next years, JYNT will show a very strong growth in Earnings Per Share. The EPS will grow by 44.54% on average per year.
The Revenue is expected to decrease by -22.13% on average over the next years. This is quite bad
EPS Next Y84.93%
EPS Next 2Y105.18%
EPS Next 3Y44.54%
EPS Next 5YN/A
Revenue Next Year-54.7%
Revenue Next 2Y-30.66%
Revenue Next 3Y-22.13%
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
JYNT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 18.20, JYNT is valued on the expensive side.
JYNT's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. JYNT is cheaper than 68.32% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.23. JYNT is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 18.2 |
4.2 Price Multiples
Compared to the rest of the industry, the Price/Free Cash Flow ratio of JYNT is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 80.61 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
JYNT's earnings are expected to grow with 44.54% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y105.18%
EPS Next 3Y44.54%
5. Dividend
5.1 Amount
No dividends for JYNT!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
8.85
+0.13 (+1.49%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners78.47%
Inst Owner Change0%
Ins Owners22.97%
Ins Owner Change2.03%
Market Cap131.60M
Revenue(TTM)91.63M
Net Income(TTM)-970.20K
Analysts76.36
Price Target10.97 (23.95%)
Short Float %7.28%
Short Ratio7.36
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.07%
Min Revenue beat(2)-2.34%
Max Revenue beat(2)-1.81%
Revenue beat(4)0
Avg Revenue beat(4)-14.21%
Min Revenue beat(4)-51.14%
Max Revenue beat(4)-1.53%
Revenue beat(8)3
Avg Revenue beat(8)-6.24%
Revenue beat(12)3
Avg Revenue beat(12)-4.83%
Revenue beat(16)5
Avg Revenue beat(16)-4.04%
PT rev (1m)0%
PT rev (3m)-27.73%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-54.29%
EPS NY rev (1m)0%
EPS NY rev (3m)-1200%
Revenue NQ rev (1m)-1.72%
Revenue NQ rev (3m)-7.2%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.47%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 18.2 | ||
| P/S | 1.44 | ||
| P/FCF | 80.61 | ||
| P/OCF | 42.85 | ||
| P/B | 5.8 | ||
| P/tB | 5.8 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.01
EYN/A
EPS(NY)0.49
Fwd EY5.49%
FCF(TTM)0.11
FCFY1.24%
OCF(TTM)0.21
OCFY2.33%
SpS6.16
BVpS1.53
TBVpS1.53
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.4% | ||
| ROE | -4.27% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 78.26% | ||
| FCFM | 1.78% |
ROA(3y)-7.05%
ROA(5y)1.52%
ROE(3y)-28.39%
ROE(5y)0.48%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.87%
GM growth 5Y-2.53%
F-Score6
Asset Turnover1.32
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 78.79% | ||
| Cap/Sales | 1.57% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.83 | ||
| Quick Ratio | 1.83 | ||
| Altman-Z | 2.8 |
F-Score6
WACC9.07%
ROIC/WACCN/A
Cap/Depr(3y)57.36%
Cap/Depr(5y)93.23%
Cap/Sales(3y)6.25%
Cap/Sales(5y)6.57%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)99.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%109.52%
EPS Next Y84.93%
EPS Next 2Y105.18%
EPS Next 3Y44.54%
EPS Next 5YN/A
Revenue 1Y (TTM)-24.15%
Revenue growth 3Y-13.43%
Revenue growth 5Y1.36%
Sales Q2Q%-55.69%
Revenue Next Year-54.7%
Revenue Next 2Y-30.66%
Revenue Next 3Y-22.13%
Revenue Next 5YN/A
EBIT growth 1Y-575.96%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year312.75%
EBIT Next 3Y60.95%
EBIT Next 5YN/A
FCF growth 1Y-85.24%
FCF growth 3Y6.31%
FCF growth 5Y15.29%
OCF growth 1Y-81.35%
OCF growth 3Y-12.05%
OCF growth 5Y4.6%
JOINT CORP/THE / JYNT FAQ
What is the ChartMill fundamental rating of JOINT CORP/THE (JYNT) stock?
ChartMill assigns a fundamental rating of 4 / 10 to JYNT.
Can you provide the valuation status for JOINT CORP/THE?
ChartMill assigns a valuation rating of 4 / 10 to JOINT CORP/THE (JYNT). This can be considered as Fairly Valued.
How profitable is JOINT CORP/THE (JYNT) stock?
JOINT CORP/THE (JYNT) has a profitability rating of 3 / 10.
How financially healthy is JOINT CORP/THE?
The financial health rating of JOINT CORP/THE (JYNT) is 6 / 10.